OGI
HealthcareOrganigram Global Inc.
$1.69
$-0.04 (-2.31%)
Jan 5, 2026
Price History (1Y)
Analysis
Organigram Global Inc. is a company listed in the Healthcare sector and operates within the Drug Manufacturers - Specialty & Generic industry. With a market capitalization of $227.24 million, it has significant scale compared to other companies in its industry. Organigram employs 1139 people and generates revenue of $259.18 million on a trailing twelve-month basis. The company's financial health is characterized by low profitability metrics, with gross margin at 34.8%, operating margin at 1.5%, and profit margin at -9.6%. Its returns on equity (ROE) and assets (ROA) are also negative, at -6.6% and -2.0%, respectively. On the balance sheet side, Organigram has a moderate level of debt ($8.75 million) compared to its cash holdings ($29.03 million), resulting in a debt-to-equity ratio of 2.10. In terms of valuation context, Organigram's forward price-to-earnings ratio is 33.14 and its price-to-book ratio is 0.89. Its price-to-sales ratio is also relatively low at 0.88. The company's enterprise value-to-EBITDA (EV/EBITDA) multiple is significantly higher, at 370.00.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Organigram Global Inc.
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.
Visit website →Key Statistics
- Market Cap
- $227.24M
- P/E Ratio
- N/A
- 52-Week High
- $2.24
- 52-Week Low
- $0.85
- Avg Volume
- 955.05K
- Beta
- 2.27
Company Info
- Exchange
- NMS
- Country
- Canada
- Employees
- 1,139